Search Close

Neal E. Rothschild, MD

Primary Specialties:
  • Oncology/Hematology  (Board Certified)
  • Hematology/Oncology  (Board Certified)

Visit Website [+]

Accepting New Patients
Insurance Accepted:
  • Avmed
  • Ambetter
  • Amerigroup
  • United Healthcare
  • Beech Street
  • Molina
  • Medicare
  • Multiplan/ PHCS
  • Neighborhood Health Plan
  • Preferred Care Partners
  • BCBS
  • Cigna
  • Aetna
  • Coventry
  • Railroad Medicare
  • Multiplan
  • WellCare
  • Evolutions
  • Workers' Compensation
  • America's Choice Provider Network
  • Prestige Health Choice
  • Simply Healthcare
  • FL Breast and Cervical Cancer Program
  • Health Care District of Palm Beach County
  • WellMed
  • Education

    Education

    Medical School:

    UMDNJ-New Jersey Medical School, Newark ,NJ

    Internship:

    Georgetown University Hospital, Washington, DC

    Residency:

    Georgetown University Hospital, Washington, DC

    Fellowship:

    Georgetown University Hospital, Washington, DC

    Board Certification:

    American Board of Internal Medicine -- Hematology; Internal Medicine; Medical Oncology
  • Research & Publications

    Research & Publications

    Publications

    Rothschild NE, Minard JG: Developme nt of New Diagnostic Procedures for the evaluation of Sleep Disorders. Bul Mcd Sci NJ 27-30, Spring. I979

    Brett AS, Rothschild NE , Perry M: Identification of Drug Overdose Patients not requiring intensive care unit admissio n. Clin Res 33:7 16A, 1985 (abstr)

    Brett AS, Rothschild NE, Perry M , Gray RG : Predicting the Clinical Course in Intentional Drug Overdose: Implica ions for Utilizat ion of the Intensive Care Unit.Arch Inn Med 147: 133-137, 1987

    Rothschild NE, Sacher RA : The Polycythemias, in Pittiglio DH and Sacher RA (eds): Clinical Hematology and Fundamentals of Hemostasis. Philadelphia, F.A. Davis, 1987, p. I82- I 93

    Bollomley WK., Gabriel SA, Corio RL,Jacobson RJ, Rothschild NE : Histiocytosis X : A review and Report of an Oral Soft Tissue Lesion. Oral Surgery, Oral Medicine. Oral Pathology 63: 228-231, 1987

    Rothschild NE , Erickson B, Sisk R. Korec S, Lesesne JB, Keller J, Arbus M , Chiazzc L,Neefc JR, Woolley P : Cancer-associated Hemolytic Uremic Syndrome: A Registry Update and Analysis of Factors Predicting Extended Survival. PROC ASCO 6:266, 1987.

    Publications

    Rothschild NE , Gray RG , Smith L, Matelski H, Ahlgren J: Phase II Study of Aminogluteth i mide in Advanced Ovarian Cancer. PROC ASCO 6: 1 1 5, 1987

    Ahlgren J, Gray RG, Rothschild NE, Richardson C: Phase II Study of Continuous Infusion 5-Fiouraouracil Plus Weekly Cisplatin as Second Line Therapy for Advanced Colorectal Adenocarcinoma. PROC ASCO 6:83, 1987

    Le Chevalier T, Tremblay C, Rouesse J , Spielmann M , Rothschild NE,Gray R, Ahlgren J, Byrne P, Woolley P : Phase II Trial of Methotrexate-FAM in Adenocarcinoma of Unknown Primary. PROC ASCO 6: 130. 1987

    Gray R, Rothschild NE , Ahlgren J, Ellison N , Lokich J , Heim W: Phase II Study of Menogaril in Non -Small Cell Lung Cancer. PROC ASCO 6: 174. 1987

    Rothschild NE, Woolley PV: Colon Cancer, in Magrath I (ed): New and Potent ial Approaches to Cancer Therapy. Springer Verlag, 1988.

    Presentations At National Meetings

    Cancer Associated Hemoytic-Uremic Syndrome: A Registry Update and Analysis of Factors Predicting Extended Survival American Society of Clinical Oncology, May, 1987